Delivery Order SPE2DR25D3201-SPE2DR26FT4ZB
Award Date 12/29/25
Potential Completion Date 1/21/26
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The delivery order, valued at $2,615.52, is for the supply of 250 mg/5 ml syringes of the medication FASLODEX, with a performance period through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop...
- This is a $4,017.95 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FASLODEX 250 MG/5 ML SYRINGE 5ML, a pharmaceutical product, with a performance period through May 29, 2025. This award is not a set-aside and is under a firm fixed-price pricing arrangement. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,530.00 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,370.92 to AmerisourceBergen Drug Corp for the supply of Fulvestrant 250 mg/5 mL syringes on April 23, 2025, with an ultimate completion date of April 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,928.60 to AmerisourceBergen Drug Corp for Fulvestrant 250 mg/5 ml syringes on November 14, 2025, with completion targeted for November 17, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's existing pharmaceutical supply contract vehicle with DLA. The product will be performed at the vendor's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes (5 mL quantity) with a contract ceiling value of $1,224.00. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and was awarded competitively without set-aside restrictions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $38,412.50 for GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $4,795.02 delivery order to AmerisourceBergen Drug Corp for Fasenra Pen 30 mg/ml, a pharmaceutical product for military healthcare supply needs. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of December 22, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- AmerisourceBergen Drug Corp received a delivery order award valued at $2,275.00 from the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, for Fasenra Pen 30 mg/ml pharmaceutical product. This is a firm fixed price delivery order with a completion date of August 29, 2025, and no set-aside designation was applied. The award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $27.3K by the Defense Logistics Agency's Medical Supply Chain on June 30, 2025, for the supply of Fasenra Pen 30 mg/mL, a prescription pharmaceutical product. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be completed by July 22, 2025, and work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...